BlackThorn Therapeutics
A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.
5
Funding Rounds
$228.0m
Money raised
Overview
A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.
- Website:
- Business model: B2C
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company BlackThorn Therapeutics has raised a total of $98m in funding over 5 rounds.
Key Insights:
- Blackthorn Therapeutics Funding Round 2019: $76m
- BlackThorn Therapeutics funding round, June 2017: $8m
- BlackThorn Therapeutics Series A round, January 2017: $14m
- BlackThorn Therapeutics Series A round January 2017: $54m
- BlackThorn Therapeutics Series B round, June 2019: $76m
Blackthorn Therapeutics Funding Round 2019
$76m
BlackThorn Therapeutics funding round, June 2017
$8m
BlackThorn Therapeutics Series A round, January 2017
$14m
BlackThorn Therapeutics Series A round January 2017
$54m
BlackThorn Therapeutics Series B round, June 2019
$76m
Industries
BlackThorn Therapeutics is active in the following industries: